ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 716825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 716825; 2) Community: the network communities that were significantly associated with the response to NSC 716825; 3) Molecule: the relationships between components within communities and NSC 716825; 4) MDR: the compounds that were significantly associated with the NSC 716825.

NSC Compound Enrichment Correlation
NSC 658855 Null 0.00349006332443474 0.46162934
NSC 729529 Null 0.00481395551057382 0.29225812
NSC 642071 Null 0.00481395551057388 0.36567217
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.00483583379453731 -0.0045914913
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.00483583379453734 -0.012498353
NSC 359415 Null 0.00483583379453734 0.43600235
NSC 623606 7-Nitro-1,2,4-benzotriazin-3-amine-1,4-dioxide 0.00483583379453734 0.37605184
NSC 727282 2-Bromo-3-methoxy-9,10-dihydro-9,10-[1,2]benzenoanthracene-1 ,4,5,8-tetraone. 0.00577660600506179 -0.030198421
NSC 142475 Null 0.00706774869341649 0.092480217
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.00706774869341649 0.23430081
Total:40  Current:2    [First] [Prev] [Next] [Last]